Blue Ribbon Highlights Session Will Feature Best Poster Presentations from 20th International Congress

FOR IMMEDIATE RELEASE
Media Contact: Elizabeth Clausen, +1 414-276-2145, eclausen@movementdisorders.org
 

Blue Ribbon Highlights Session Will Feature Best Poster Presentations from
20th International Congress of Parkinson’s Disease and Movement Disorders


BERLIN – The annual Blue Ribbon Highlights Session will take place on Thursday, June 23rd, during the 20th International Congress of Parkinson’s Disease and Movement Disorders. This session will provide a critical review of the best poster presentations by a panel of experts, highlighting the relevance, novelty, and quality of both clinical and basic research presented by delegates.

Of the over 2,200 abstracts accepted for presentation at this year’s International Congress, only a select few have been given this special recognition. The Blue Ribbon Highlights Session is chaired by C. Warren Olanow, New York, NY, USA and Louis Tan, Singapore, and the panel will be led by Marie-Francoise Chesselet, Los Angeles, CA, USA, and Caroline Tanner, San Francisco, CA, USA.

Christine Klein, Director of the Institute of Neurogenetics Head at the University of Luebeck, Luebeck, Germany, and Chair of the 2016 MDS Congress Scientific Program Committee states, “The International Congress serves as an excellent forum bringing together health professionals and scientists with the shared goal of improving our understanding of movement disorders and providing better care to our patients. Critically discussing cutting-edge research with peers has a high imperative, as it will continuously improve what is considered current knowledge and best practice.

The poster presentations reflect the most recent and the most exciting work being done by the thousands of delegates attending the meeting. This year’s Congress is the 20th of its kind and, based on the current number of registered delegates and submitted abstracts, will likely become the largest to date. It is wonderful to see the growing number of clinician- and basic scientists attracted by the Congress and a privilege to be able to hear the future of our specialty in this year’s Blue Ribbon Session.”

About the 20th International Congress of Parkinson's Disease and Movement Disorders: Meeting attendees gather to learn the latest research findings and state-of-the-art treatment options in Movement Disorders, including Parkinson's disease. Over 5,000 physicians and medical professionals from more than 86 countries will be able to view over 2,200 scientific abstracts submitted by clinicians from around the world.

About the International Parkinson and Movement Disorder Society: The International Parkinson and Movement Disorder Society (MDS), an international society of over 5,000 clinicians, scientists, and other healthcare professionals, is dedicated to improving patient care through education and research. For more information about MDS, visit www.movementdisorders.org.

Top